Theodore L. Munsat

Theodore L. Munsat's AcademicInfluence.com Rankings

Theodore L. Munsat

Medical

#3260

World Rank

#3722

Historical Rank

Neurology

#300

World Rank

#382

Historical Rank

medical Degrees

Download Badge

Medical

Theodore L. Munsat's Degrees

Doctorate Medicine University of Chicago

Why Is Theodore L. Munsat Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Theodore L. Munsat's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) (4514)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis (2009) (2366)
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany) (1992) (540)
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) (1999) (474)
International SMA consortium meeting (1992) (354)
The spectrum of neurologic disease associated with anti‐GM1 antibodies (1990) (261)
Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (1999) (229)
Quantitative motor assessment in amyotrophic lateral sclerosis (1986) (222)
Consensus guidelines for the design and implementation of clinical trials in ALS (1999) (206)
Lead Exposure and Amyotrophic Lateral Sclerosis (2002) (174)
International SMA Collaboration (1991) (164)
The natural history of motoneuron loss in amyotrophic lateral sclerosis (1988) (150)
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14 (1995) (140)
Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis (1988) (139)
Serum enzyme alterations in neuromuscular disorders. (1973) (132)
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis (1998) (123)
Inflammatory myopathy with facioscapulohumeral distribution (1972) (117)
Quantification of neurologic deficit (1989) (116)
Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis (2006) (116)
Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis (1999) (112)
Effects of nerve stimulation on human muscle. (1976) (101)
MYOPATHY WITH ATYPICAL MITOCHONDRIA IN TYPE I SKELETAL MUSCLE FIBERS: HITOCHEMICAL AND ULTRA STRUCTURAL STUDY (1967) (99)
Evidence for early impairment of verbal intelligence in Duchenne muscular dystrophy (1974) (82)
Relation of multiple cranial nerve dysfunction to the Guillain-Barré syndrome (1965) (82)
New evidence for excessive accumulation of Z-band material in nemaline myopathy. (1965) (80)
Promoting excellence in end‐of‐life care in ALS (2005) (80)
Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. (2003) (76)
Therapy of myotonia; (1967) (75)
Clinical trials of riluzole in patients with ALS (1996) (73)
Familial myoadenylate deaminase deficiency and exertional myalgia (1982) (70)
Animal models of alcoholic neuropathy: Morphologic, electrophysiologic, and biochemical findings (1979) (69)
Recombinant growth hormone treatment of amyotrophic lateral sclerosis (1993) (69)
High‐dose dextromethorphan in amyotrophic lateral sclerosis: Phase I safety and pharmacokinetic studies (1994) (66)
The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials (1993) (65)
A standardized forearm ischemic exercise test (1970) (64)
Linkage analysis in familial amyotrophic lateral sclerosis (1989) (63)
NEUROGENIEC MUSCULAR ATROPHY OF INFANCY WITH PROLONGED SURVIVAL (1969) (61)
Familial myopathy with probable lysis of myofibrils in type I fibers (1971) (60)
Measurement of isometric force in children with and without Duchenne's muscular dystrophy. (1992) (59)
Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis. (1983) (59)
The Schwartz-Jampel syndrome (1974) (58)
Nemaline myopathy. A histopathologic and histochemical study. (1967) (58)
Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy (1998) (57)
A comparison of three measures of disease progression in ALS (1996) (56)
Centronuclear ("myotubular") myopathy. (1969) (55)
Dietary Intake of Calcium, Magnesium and Antioxidants in Relation to Risk of Amyotrophic Lateral Sclerosis (2000) (55)
Retrograde axonal transport of lead in rat sciatic nerve (1981) (54)
Quantitative assessment of neuromuscular deficit in ALS. (1987) (49)
Dominant inheritance of McArdle syndrome. (1976) (48)
Tubular aggregates in subclinical alcoholic myopathy (1975) (47)
A double‐blind controlled trial of bovine brain gangliosides in amyotrophic lateral sclerosis (1984) (40)
New myopathy with mitochondrial enzyme hyperactivity. Histochemical demonstration. (1967) (39)
Intrathecal thyrotropin‐releasing hormone does not alter the progressive course of ALS (1992) (38)
Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (1986) (36)
Amyotrophic lateral sclerosis (1986) (36)
Intrathecal administration of natural human nterferon alpha in amyotrophic lateral sclerosis (1986) (36)
Clinical manifestations and diagnosis of amyloid polyneuropathy (1962) (35)
MUSCLE LACTATE DEHYDROGENASE PATTERNS IN TWO TYPES OF X-LINKED MUSCULAR DYSTROPHY. (1965) (34)
Neurologic services in Sub-Saharan Africa: a case study among Zambian primary healthcare workers (2002) (34)
Prolonged ethanol consumption produces persistent alterations of cholinergic function in rat brain. (1980) (33)
Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. (1989) (32)
Conjugal motor neuron disease (1982) (30)
Regeneration of human muscle. A morphologic and histochemical study of normal and dystrophic muscle after injury. (1972) (30)
Total body irradiation not effective in inclusion body myositis (1986) (29)
Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]Quinuclidinyl benzilate binding in rats (1979) (28)
Neurodegenerative disorders; mechanisms and prospects for therapy Edited by D. L. Price, H. Thoenen and A. J. Aguayo. Published 1991 by Wiley, Chichester. ISBN 0 471 92979 4, 301 pp. Price ♠50 (1992) (28)
Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials (2012) (27)
Experimental serotonin myopathy (1977) (27)
Needle muscle biopsy with the automatic Biopty instrument (1992) (27)
Serum creatine phosphokinase levels and prednisone treated muscle weakness (1977) (26)
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome (2001) (26)
The Schwartz-Jampel syndrome. Its clinical, physiological and histological expressions. (1974) (26)
Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. (1986) (25)
Spinal muscular atrophy 32nd ENMC international workshop Naarden, The Netherlands, 10–12 March 1995 (1996) (24)
Spinal cord TRH deficiency is associated with incomplete recovery of denervated muscle in the rat (1988) (23)
Guidelines on the vegetative state (1989) (23)
Poliomyelitis--new problems with an old disease. (1991) (23)
Effect of increased maxillo-mandibular relationship on isometric strength in TMD patients with loss of vertical dimension of occlusion. (1997) (22)
Amyotrophic Lateral Sclerosis: A Guide for Patients and Families (2001) (22)
Development of measurement techniques (1996) (21)
Polymyositis without inflammation. (1974) (21)
Amantadine and guanidine are ineffective in ALS (1981) (21)
Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis. (1987) (21)
Clinical trials in ALS: measurement and natural history. (1991) (21)
Inflammatory myopathy in oculopharyngeal dystrophy (1979) (18)
Pathogenesis and therapy of amyotrophic lateral sclerosis (1995) (18)
The effects of acute and chronic ethanol administration on twitch and tetanic force production by rat gastrocnemius muscle in situ (1980) (18)
Neurogenic muscular atrophy of infancy with prolonged survival. The variable course of Werdnig-Hoffmann Disease. (1969) (17)
The relationship of lower-limb muscle force to walking ability in patients with amyotrophic lateral sclerosis. (1999) (17)
Developing a neurology training program in Honduras: A joint project of neurologists in Honduras and the World Federation of Neurology (2007) (17)
Response to total body irradiation in dermatomyositis (1988) (17)
Effect of ethanol on lactic acid production by exercised normal muscle (1978) (16)
A comparative clinical study of the vacuum extractor and forceps (1963) (16)
International Issues: Educational programs of the World Federation of Neurology (2009) (14)
Prolonged Intrathecal Infusion of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis a (1988) (14)
Intravascular contrast media and neuromuscular junction disorders (1986) (14)
Pharrnacokinetics of intrathecal thyrotropin‐releasing hormone (1987) (14)
Clinical trials in neuromuscular disease (1990) (14)
Lecithin is not effective in amyotrophic lateral sclerosis (1982) (14)
Lower extremity muscle force measures and functional ambulation in patients with amyotrophic lateral sclerosis. (1998) (14)
Reflex sympathetic dystrophy: Successful treatment by transcutaneous nerve stimulation (1978) (14)
PSEUDO-MYASTHENIA GRAVIS: A CONVERSION REACTION (1966) (13)
Indomethacin reduces the side effects of intrathecal interferon. (1984) (12)
Anticholinesterase abuse in myasthenia gravis (1984) (11)
Preliminary observations on long-term muscle force changes in the post-polio syndrome. (1987) (11)
Excitotoxins and amyotrophic lateral sclerosis. (1990) (11)
The AAN launches a new education program (1994) (11)
Developing normalized strength scores for neuromuscular research (2013) (11)
Continuing medical education in developing countries (2001) (11)
A neuromuscular syndrome of scapuloperoneal distribution. (1970) (11)
Skeletal muscle. Basic and clinical aspects and illustrative new diseases. (1967) (11)
TRH and Diseases of the Motor System a (1989) (10)
A comparative clinical study of the vacuum extractor and forceps. II. Evaluation of the newborn. (1963) (10)
Serotonin and myoclonic seizures. (1977) (10)
Programmed feeding as a model of chronic alcoholism in the rat (1977) (10)
Effect of spinal cord TRH deficiency on lower motorneuron function in the rat (1987) (10)
Post-Polio Syndrome (1990) (10)
Neurology education in Latin America and the World Federation of Neurology (2010) (10)
Neuromuscular manifestations of Wegener's granulomatosis (1993) (9)
The lysosome: a role in disease. (1973) (9)
Don't throw out the baby with the bathwater (1987) (9)
American Academy of Neurology evidence-based review): Report of the Quality Standards Subcommittee of the Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an (2006) (9)
PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY (1975) (8)
PHARMACOLOGIC THERAPY OF DYSTROPHY IN MAN AND ANIMALS * (1979) (8)
Issues in clinical trial design I (1996) (8)
Issues in amyotrophic lateral sclerosis clinical trial design. (1995) (7)
Automated system for the analysis of muscle and nerve biopsies. (1987) (7)
International SMA Consortium Summary of meeting held 30 April–2 May 1993, Cambridge Marriott Hotel (1994) (7)
Dystonic postures generated from complex repetitive discharges (1996) (6)
Myasthenia Gravis: Signs, Symptoms, Diagnosis, Immunology, and Current Therapy (1981) (6)
Neurogenic muscular atrophy of infancy with prolonged survival--the variable course of Werdnig-Hoffmann disease. (1968) (5)
Defects in purine metabolism and neurologic disease. (1968) (5)
Creatine phosphokinase alterations in neuromuscular diseases. (1977) (5)
Hereditary hypertrophic neuropathy. Report of two cases of an autosomal recessive variant. (1970) (5)
AEROEMBOLISM TREATED BY HYPOTHERMIA. REPORT OF A CASE. (1965) (4)
Slowing down ALS ™ is this good or bad? (2001) (4)
The clinical presentation of nemaline myopathy. (1969) (4)
Pharmacokinetics of intrathecal thyrotropin-releasing hormone. (1987) (4)
Familial granulovacuolar lobular myopathy with electrical myotonia (1982) (3)
Electromyographic characteristics of congenital and early onset motor unit diseases. (1971) (3)
[Continuing medical education in Russian neurology and neurosurgery]. (2009) (3)
A comparative clinical study of the vacuum extractor and forceps. I. Preliminary observations. (1963) (2)
Negative drug trial bias (1988) (2)
The Differential Diagnosis of Neuromuscular Weakness in Infancy and Childhood (1967) (2)
Pathogenesis and therapy of amyotrophic lateral sclerosis. Introduction. (1995) (2)
Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis. (1995) (2)
Clinical Trial Methodology (1995) (2)
Whose responsibility? A call for active participation. 1989 American Academy of Neurology presidential address. (1989) (2)
Detection of the muscular dystrophy carrier. (1971) (2)
Retrograde axonal transport of lead in the etiology of ALS (1980) (1)
Idiopathic non-inflammatory neuromyopathy. (1966) (1)
Mutations of the glutamate transporter gene EAAT2 do not cause the abnormal EAAT2 transcripts in patients with amyotrophic lateral sclerosis (1997) (1)
Chapter 4: Myotonia (1979) (1)
Relation ofmultiple cranial nervedysfunction totheGuillain-Barre syndrome (1965) (1)
Neurological care in the East Los Angeles ghetto. (1972) (1)
Neuromuscular disease Editorial overview (1993) (1)
Summary of meeting (clinical and plenary meetings), 4–6 March 1994, Naarden, The Netherlands (1995) (1)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1986. A 29-year-old woman with slowly progressive proximal-muscle weakness. (1986) (1)
Case 43-1992 (1992) (1)
The Differential Diagnosis of Neuromuscular Weakness in Infancy and Childhood (1967) (1)
Neuromuscular transmission defect in inherited polyneuropathy. (1985) (1)
Autosomal Dominant Myopathy Presenting as Kyphoscoliosis (1987) (1)
THYROTROPIN-RELEASING HORMONE (TRH) IMMUNOREACTIVITY IN HUMAN SPINAL CORD (1985) (0)
Metabolic myopathies. (1979) (0)
Measurement of muscle weakness (1991) (0)
Letter: Prednisone in Duchenne muscular dystrophy. (1975) (0)
Sclerosis Walking Ability in Patients With Amyotrophic Lateral The Relationship of Lower-Limb Muscle Force to (2016) (0)
Development of measurement techniques. Discussion (1996) (0)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 43--1992. A 70-year-old man with progressive muscle weakness and agitated depression. (1992) (0)
Current neurology. Edited by H. Richard Tyler and David M. Dawson, 499 pp, illus, Houghton Mifflin, Boston, 1978. $29.00 (1979) (0)
MANDIBULAR FRACTURE AND MYOTONIC DYSTROPHY; REPORT OF A CASE. (1964) (0)
Serum enzymes in the diagnosis of neuromuscular disorders. (1971) (0)
Letters to the editor (0)
Indomethacin, interferons, and multiple sclerosis (1987) (0)
Ethanol and muscle lactate. (1978) (0)
Neurology case studies : 55 case histories related to neurological diseases (1972) (0)
Pharmocologic therapy of dystrophy in man and animals. (1979) (0)
Author and Subject Index (2006) (0)
Care of the Patient with ALS Page 3 (2003) (0)
Use of quantitative myometry in the evaluation of myoblast transfer therapy. (1990) (0)
The amyotrophic lateral sclerosis health state scale and the effect of riluzole (1997) (0)
Meeting announcements (2007) (0)
Obituary. Morton K. Rubinstein, MD 1930-1981 (1981) (0)
Muscle Disorders in Childhood (1979) (0)
Septal Defect Related to Intrauterine Hypothermia (1967) (0)
Amyotrophic lateral sclerosis: A synthesis of research and clinical practice (1999) (0)
Muscle biopsy in the diagnosis of neuromuscular disease. (1971) (0)
President Greer steps down (1987) (0)
Financing health care (1989) (0)
FSH Watch A Publication of the Facioscapulohumeral Muscular Dystrophy Society ConneCting the Community of patients , families (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Theodore L. Munsat?

Theodore L. Munsat is affiliated with the following schools: